Top compounds associated with response to CERKL


Feature Type Standardized
Nominal ANOVA
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.14 8e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA QL-X-138 GDSC1000 pan-cancer AAC 0.14 2e-06
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA alisertib CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.14 6e-06
Download CSV